Logo image of CNV.PA

CNOVA NV (CNV.PA) Stock Fundamental Analysis

EPA:CNV - Euronext Paris - Matif - NL0010949392 - Common Stock - Currency: EUR

0.0932  +0 (+0.22%)

Fundamental Rating

1

Overall CNV gets a fundamental rating of 1 out of 10. We evaluated CNV against 11 industry peers in the Broadline Retail industry. Both the profitability and financial health of CNV have multiple concerns. CNV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNV had negative earnings in the past year.
CNV had a positive operating cash flow in the past year.
In the past 5 years CNV always reported negative net income.
CNV had a positive operating cash flow in 4 of the past 5 years.
CNV.PA Yearly Net Income VS EBIT VS OCF VS FCFCNV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -15.79%, CNV is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -15.79%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNV.PA Yearly ROA, ROE, ROICCNV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 -300

1.3 Margins

CNV has a worse Gross Margin (33.44%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of CNV has grown nicely.
CNV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.98%
GM growth 5Y14.61%
CNV.PA Yearly Profit, Operating, Gross MarginsCNV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

CNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNV.PA Yearly Shares OutstandingCNV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
CNV.PA Yearly Total Debt VS Total AssetsCNV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CNV has an Altman-Z score of -0.95. This is a bad value and indicates that CNV is not financially healthy and even has some risk of bankruptcy.
CNV has a worse Altman-Z score (-0.95) than 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.95
ROIC/WACCN/A
WACC10.99%
CNV.PA Yearly LT Debt VS Equity VS FCFCNV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

2.3 Liquidity

CNV has a Current Ratio of 0.71. This is a bad value and indicates that CNV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.71, CNV is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that CNV may have some problems paying its short term obligations.
CNV has a worse Quick ratio (0.52) than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.52
CNV.PA Yearly Current Assets VS Current LiabilitesCNV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CNV have decreased strongly by -19.49% in the last year.
CNV shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.88%.
The Revenue for CNV have been decreasing by -13.89% on average. This is quite bad
EPS 1Y (TTM)-19.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.44%
Revenue 1Y (TTM)28.88%
Revenue growth 3Y-21.67%
Revenue growth 5Y-13.89%
Sales Q2Q%77.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNV.PA Yearly Revenue VS EstimatesCNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
CNV.PA Yearly EPS VS EstimatesCNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNV.PA Price Earnings VS Forward Price EarningsCNV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNV indicates a somewhat cheap valuation: CNV is cheaper than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.47
CNV.PA Per share dataCNV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CNOVA NV

EPA:CNV (4/1/2025, 7:00:00 PM)

0.0932

+0 (+0.22%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-25 2025-02-25
Earnings (Next)04-22 2025-04-22
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners98.81%
Ins Owner ChangeN/A
Market Cap32.17M
Analysts46.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF 3.09
P/B N/A
P/tB N/A
EV/EBITDA 10.47
EPS(TTM)-0.42
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.03
OCFY32.35%
SpS3.06
BVpS-1.82
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.79%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.44%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.98%
GM growth 5Y14.61%
F-Score5
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.98
Cap/Depr 63.03%
Cap/Sales 5.63%
Interest Coverage N/A
Cash Conversion 13.23%
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.52
Altman-Z -0.95
F-Score5
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)70.86%
Cap/Depr(5y)84.73%
Cap/Sales(3y)5.18%
Cap/Sales(5y)4.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.88%
Revenue growth 3Y-21.67%
Revenue growth 5Y-13.89%
Sales Q2Q%77.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.09%
OCF growth 3Y-19.67%
OCF growth 5Y-28.37%